Life
FDA Approval of Denali Medicine for Hunter Syndrome: Implications for Rare Disease Drug Development
The FDA's approval of Denali Medicine's treatment for Hunter syndrome indicates a pivotal moment in the regulatory landscape for rare disease therapies, amidst heightened scrutiny.
Editorial Staff 11 days ago